Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
06/14/2021 06/15/2021 06/16/2021 06/17/2021 06/18/2021 Date
68.98(c) 69.36(c) 69.98(c) 70.22(c) 70.14(c) Last
442 714 471 242 662 921 529 614 1 414 137 Volume
+0.55% +0.55% +0.89% +0.34% -0.11% Change
More quotes
Financials (USD)
Sales 2021 21 617 M - -
Net income 2021 1 345 M - -
Net Debt 2021 13 952 M - -
P/E ratio 2021 18,2x
Yield 2021 1,71%
Sales 2022 22 633 M - -
Net income 2022 1 541 M - -
Net Debt 2022 13 186 M - -
P/E ratio 2022 15,6x
Yield 2022 1,90%
Capitalization 24 363 M 24 355 M -
EV / Sales 2021 1,77x
EV / Sales 2022 1,66x
Nbr of Employees 124 995
Free-Float 67,8%
More Financials
Company
Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines,... 
More about the company
Ratings of Fresenius Medical Care AG & Co. KGaA
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
06/17FRESENIUS SEá : Deutsche Bank reiterates its Neutral rating
MD
06/10FRESENIUS SEá : Buy rating from Goldman Sachs
MD
06/10PRESS RELEASE : SphingoTec Expands Management Team and Appoints new CFO
DJ
06/09DGAP-DD : Fresenius Medical Care AG & Co. KGaA english
DJ
06/08FMC FRESENIUS MEDICAL CARE AG & CO K : Goldman Sachs reiterates its Buy rating
MD
06/07PRESS RELEASE : MagForce AG Supports World Brain Tumor Day and Informs about Var..
DJ
06/02ANALYST RECOMMENDATIONS : Bank of America, Bodycote, Chevron, Dow Inc, Ferguson...
06/01FMC FRESENIUS MEDICAL CARE AG & CO K : Jefferies gives a Sell rating
MD
06/01FMC FRESENIUS MEDICAL CARE AG & CO K : Goldman Sachs maintains a Buy rating
MD
06/01FRESENIUS SEá : Goldman Sachs reaffirms its Buy rating
MD
05/31FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 41 of the Wp..
EQ
05/26DGAP-DD : Fresenius Medical Care AG & Co. KGaA english
DJ
05/26PRESS RELEASE : Immatics Announces Changes to its Board of Directors
DJ
05/24SECTOR UPDATE : Health Care Stocks Still Narrowly Higher in Late Regular-Hours T..
MT
05/24SECTOR UPDATE : Health Care Stocks Higher in Moderation
MT
More news
News in other languages on FRESENIUS MEDICAL CARE AG & CO. KGAA
06/15MÄRKTE EUROPA/DAX vor Fed-Sitzung weiter freundlich
06/14Nestlé fait entrer un représentant du WWF au sein d'un de ses organes
06/14STUDI LEGALIá : Legance con Ihg in cessione ramo dialisi
06/11MILAN STOCK EXCHANGE : Borsa Milano indici quasi fermi, strappano Reno Medici, I..
06/11MÄRKTE EUROPA/Gut behauptet - fallende Renditen stützen
More news
Analyst Recommendations on FRESENIUS MEDICAL CARE AG & CO. KGAA
More recommendations
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Average target price 80,08 $
Last Close Price 83,18 $
Spread / Highest target 16,2%
Spread / Average Target -3,73%
Spread / Lowest Target -55,5%
EPS Revisions
Managers and Directors
NameTitle
Rice Powell Chief Executive Officer
Helen Giza Chief Financial Officer
Dieter Schenk Chairman-Supervisory Board
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer
Sector and Competitors